Neurologia medico-chirurgica
Online ISSN : 1349-8029
Print ISSN : 0470-8105
ISSN-L : 0470-8105
Intratumoral Administration of Tumor Necrosis Factor-α for Malignant Gliomas —Two Case Reports—
Toshiki YAMASAKIKouzo MORITAKEJonathan T. PAINEMinoru FUKUDAFumihito OHTAHiroki NAITOH
Author information
JOURNAL FREE ACCESS

1994 Volume 34 Issue 4 Pages 216-220

Details
Abstract
Two patients with histologically verified glioblastoma multiforme and anaplastic astrocytoma were treated with four courses of intratumoral administration of human natural tumor necrosis factor-α (TNF) (specific activity 2.0 × 106 Japan reference unit [JRU]/mg protein) at intervals of 3-5 months. Each consisted of eight to 10 serial injections, ranging from 5 × 103 to 104 JRU/injection, at intervals of 3-5 days. There was no simultaneous administration of steroids. Serial neurological examinations and neuroimaging studies with computed tomography and magnetic resonance imaging demonstrated partial responses ranging from 28 and 36 months in duration. No significant TNF-related brain edema, intracerebral bleeding, or neurotoxicity occurred. Local immunotherapy with TNF may be used safely to contribute to therapeutic efficacy.
Content from these authors
© The Japan Neurosurgical Society
Previous article Next article
feedback
Top